PAKOLA STEVE 内部人交易：近期 SEC Form 4 交易
过去 18 个月，PAKOLA STEVE（CIK 1700659）在 1 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-08-04）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-04 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 卖出 | 7,468 | $72,365 |
| 2026-07-06 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 买入 | 2,161 | $16,985 |
| 2026-07-06 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 卖出 | 2,161 | $29,476 |
| 2026-07-01 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 卖出 | 19,608 | $216,472 |
| 2026-07-01 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 买入 | 36,725 | $288,658 |
| 2026-07-01 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 卖出 | 36,725 | $472,284 |
| 2026-05-13 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 卖出 | 15,309 | $168,705 |
| 2026-03-12 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 卖出 | 5,124 | $53,033 |
| 2026-02-03 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 卖出 | 5,267 | $58,780 |
| 2026-01-08 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 买入 | 65,847 | $0 |
| 2026-01-06 | REGENXBIO Inc. (RGNX) | Chief Medical Officer | 卖出 | 18,247 | $262,757 |
来源：SEC Form 4 申报文件 · 截至 2026-08-04